Alcon Inc Asset Turnover Ratio (ALC), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Alcon inc   (NYSE: ALC)
 

Alcon Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Alcon Inc asset turnover ratio, the ability of Alcon Inc 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.41 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as ALC's position remain challenging.

Within sector 175 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 3531.

Asset Turnover Ratio Definition



ALC Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Asset Change -17.93 % 3.98 % -22.35 % 3.98 % -4.31 %
Y / Y Revenue Change 4.94 % - 4.01 % - 4.82 %
Asset Turnover Ratio (TTM) 0.41 - 0.38 - 0.35
ALC's Total Ranking # 3531 # # # #
Seq. Asset Change 1.21 % -0.89 % 0.9 % -18.91 % 28.23 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 176
Healthcare Sector # 516
Overall Market # 3531

Asset Turnover Ratio Statistics
High Average Low
4.57 3.02 0.8
(Dec 31 2023)   0







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Organogenesis Holdings Inc   1.11 $ 564.169  Millions$ 509.270  Millions
Tela Bio Inc   1.10 $ 79.341  Millions$ 71.948  Millions
Angiodynamics Inc   1.10 $ 305.655  Millions$ 277.836  Millions
Lifeloc Technologies Inc   1.10 $ 9.027  Millions$ 8.207  Millions
Nuwellis Inc   1.09 $ 8.270  Millions$ 7.577  Millions
Harvard Bioscience Inc   1.08 $ 85.910  Millions$ 79.489  Millions
Phibro Animal Health Corporation  1.08 $ 1,465.016  Millions$ 1,356.146  Millions
Esperion Therapeutics Inc   1.07 $ 403.135  Millions$ 375.255  Millions
Myomo Inc   1.07 $ 40.888  Millions$ 38.063  Millions
Axogen inc   1.07 $ 225.208  Millions$ 209.926  Millions
Vaso Corporation  1.07 $ 89.096  Millions$ 83.330  Millions
Apellis Pharmaceuticals Inc   1.07 $ 1,003.782  Millions$ 940.664  Millions
Treace Medical Concepts Inc   1.06 $ 212.690  Millions$ 199.865  Millions
Myriad Genetics Inc   1.06 $ 823.600  Millions$ 779.525  Millions
Neuronetics Inc   1.05 $ 148.308  Millions$ 140.914  Millions
Premier Air Charter Holdings Inc   1.05 $ 31.878  Millions$ 30.459  Millions
Rigel Pharmaceuticals Inc  1.03 $ 294.282  Millions$ 284.709  Millions
Regen Biopharma Inc   1.03 $ 0.237  Millions$ 0.229  Millions
Spero Therapeutics Inc   1.02 $ 66.802  Millions$ 65.729  Millions
Quipt Home Medical Corp   1.01 $ 264.974  Millions$ 261.171  Millions
Argenx Se  1.01 $ 8,399.366  Millions$ 8,305.922  Millions
Biodesix Inc   1.01 $ 88.499  Millions$ 87.545  Millions
Milestone Scientific Inc   1.01 $ 8.408  Millions$ 8.358  Millions
Nrc Health  1.00 $ 137.390  Millions$ 136.790  Millions
National Vision Holdings Inc   1.00 $ 1,987.488  Millions$ 1,980.214  Millions
Arcutis Biotherapeutics Inc   1.00 $ 376.072  Millions$ 375.122  Millions
Addus Homecare Corp  1.00 $ 1,421.874  Millions$ 1,419.190  Millions
Nexgel Inc   1.00 $ 10.509  Millions$ 10.557  Millions
Ensign Group Inc  0.99 $ 5,057.841  Millions$ 5,094.886  Millions
Omada Health Inc   0.99 $ 259.186  Millions$ 261.685  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.